Abstract
Excellent long-term results are observed in patients with clinical stage I high-risk nonseminomatous germ-cell tumors after one cycle of adjuvant modified-BEP chemotherapy.
Author supplied keywords
Cite
CITATION STYLE
APA
Vidal, A. D., Thalmann, G. N., Karamitopoulou-Diamantis, E., Fey, M. F., & Studer, U. E. (2015). Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy. Annals of Oncology, 26(2), 374–377. https://doi.org/10.1093/annonc/mdu518
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free